The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Exact Sciences
Leadership - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
Patient-specific meta-analysis of 3 validation studies of the 12-gene colon cancer recurrence score assay for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.
 
Greg Yothers
Employment - Mountainview Pediatrics (I)
Consulting or Advisory Role - Orbus Therapeutics
 
Alan P. Venook
Consulting or Advisory Role - Array BioPharma; Merck Sharp & Dohme
Research Funding - Amgen; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Genentech; Roche
 
Takeharu Yamanaka
Honoraria - Bayer; Chugai Pharma; Takeda
Research Funding - Bayer (Inst); Chugai/Roche (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Yan Lin
Research Funding - Bristol Myers Squibb Foundation
 
Michael Crager
Employment - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
Travel, Accommodations, Expenses - Genomic Health
 
Calvin Y. Chao
Employment - Exact Sciences
Leadership - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
 
Frederick L Baehner
No Relationships to Disclose
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck; Takeda
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PAREXEL International Inc. (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst)